New technologies such as artificial intelligence could prove “hugely important to humanity”, says Steve Leonard, Chief Executive of SGInnovate, a government-owned company that funds deep tech startups. He believes that Singapore is poised on the cusp of a healthcare AI revolution; in the near future, intelligent digital tools will help doctors and nurses speed up diagnoses and pick out trends and patterns.
Amgen based in USA is changing how AI is innovating predictive care. Amgen is the world’s largest independent biotechnology company, is at the forefront of this change. The company is combining life sciences with data analytics to help tackle serious illnesses like cancer and cardiovascular disease.
Recently at the Aspen Ideas summit: Health in Colorado, Amgen discussed ways its Digital Health & Innovation (DH&I) team is using advanced data analytics techniques like artificial intelligence to solve problems for patients.
Amgen is a company that uses cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases. Amgen believes the cure for disease can be found inside each and every one of us. See what they have been up to below:
- Boosting the accuracy of risk predictions.
Amgen built a sequential neural network, capable of learning order dependence in sequence prediction problems.These approaches, inspired from state-of-the-art natural language processing algorithms, have shown relevance to healthcare applications in recent research.The models learned “fingerprints” of patients in a latent vector space to estimate sequences more commonly associated with facture patients and used a tree-based model to predict risk.Together, the neural network and sequence prediction have shown promising early results in predicting imminent fractures from the historical data set.
- Making patient care more intuitive.
- Using data to determine the most effective treatment for individual patients.
Amgen is now striving to arm clinicians with insights into the patient response of different therapies, thereby improving patient outcomes throughout the treatment journey.Amgen has partnered with GNS Healthcare (a US-based company), which specializes in analyzing both clinical trial and real-world data to model patient response to treatment using artificial intelligence and Bayesian modeling to play out different “what if” scenarios.
- Supporting compliance via real-time answers.
Amgen recognized that by pushing the boundaries of advanced text recognition, artificial intelligence could be used to provide real-time answers to questions related to compliance and regulations.Collaborating with Avata Intelligence, a leader in AI for enterprise-level solutions, Amgen created ASK, an application that uses AI and natural language processing to provide fast answers with accuracy, consistency, and confidence.
“At Amgen, our mission is to serve patients.We’re proud to be leading the way in biotechnology with advanced data analytic techniques and emerging technology solutions to help bring about this overdue transformation for patient,” said Patrick Dey, vice president of Digital Health & Innovation at Amgen.
Learn more about how Amgen is building a better biotech at www.amgen.com .